Clinical trials
Phase 2 Epilepsies, Partial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 2 |
| 2005 | 4 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 4 |
| 2013 | 2 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Recruiting | 7 |
| Terminated | 6 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 5 |
| SK Life Science, Inc. | 4 |
| UCB Pharma | 3 |
| AbbVie | 2 |
| Marinus Pharmaceuticals | 2 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 2 |
| Rapport Therapeutics Inc. | 2 |
| Shanghai Zhimeng Biopharma, Inc. | 2 |
| Supernus Pharmaceuticals, Inc. | 2 |
| Bial - Portela C S.A. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epilepsies, Partial | 39 |
| Epilepsy | 21 |
| Seizures | 16 |
| Brain Diseases | 5 |
| Drug Resistant Epilepsy | 2 |
| Epilepsy, Temporal Lobe | 2 |
| Anxiety Disorders | 1 |
| Autoimmune Diseases | 1 |
| Autoimmune Diseases of the Nervous System | 1 |
| Limbic Encephalitis | 1 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.